REFERENCES

• HughesJR.HatsukamiDK.MitchellJE.DahlgrenLA.Prevalence of smoking among psychiatric outpatients.Am J Psychiatry.19861439939973487983
   PubMed Web of Science ®Google Scholar
• LeonardS.AdlerLE.BenhammouK.et al.Smoking and mental illness.Pharmacol Biochem Behav.20017056157011796154
   PubMed Web of Science ®Google Scholar
• LajeRP.BermanJA.GlassmanAH.Depression and nicotine: preclinical and clinical evidence for common mechanisms.Curr Psychiatry Rep.2001347047411707160
   PubMedGoogle Scholar
• PaperwallaKN.LevinTT.WeinerJ.SaravaySM.Smoking and depression.Med Clin North Am.2004881483149415464109
   PubMed Web of Science ®Google Scholar
• LavioletteSR.van der KooyD.The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour.Nat Rev Neurosci.20045556514708004
   PubMed Web of Science ®Google Scholar
• WonnacottS.SidhpuraN.BalfourDJ.Nicotine: from molecular mechanisms to behaviour.Curr Opin Pharmacol.20055535915661626
   PubMed Web of Science ®Google Scholar
• DaniellWF.On the natives of Old Calabar, west coast Africa.Edinburgh New Philosophical J.184640318319
   Google Scholar
• KoelleGB.Anticholinesterase agents. In: Goodman LS, Gilman A, eds.The Pharmacological Basis of Therapeutics. New York, NY: MacMillan1970442465
   Google Scholar
• JanowskyDS.DavisJM.EI-YoussefMK.SekerkeHJ.Acetylcholine and depression.Psychosom Med.197335568
   Web of Science ®Google Scholar
• JanowskyDS.RischC.ParkerD.HueyL.JuddL.Increased vulnerability to cholinergic stimulation in affect disorder patients.Psychopharmacol Bull.198016297454928
   PubMedGoogle Scholar
• LuZL.SaldanhaJW.HulmeEC.Seven-transmembrane receptors: crystals clarify.Trends Pharmacol Sci.20022314014611879682
   PubMed Web of Science ®Google Scholar
• WessJ.Novel insights into muscarinic acetylcholine receptor function using gene targeting technology.Trends Pharmacol Sci.20032441442012915051
   PubMed Web of Science ®Google Scholar
• RosenbluethA.The autonomic nervous system.Ann Rev Physiol.19402236286
   Google Scholar
• AscherP.LargeWA.RangHP.The action of ganglion-blocking drugs studied by voltage clamp.J Physiol.197828017P
   PubMed Web of Science ®Google Scholar
• ChangeuxJP.BenoitP.BessisA.et al.The acetylcholine receptor: functional architecture and regulation.Adv Second Messenger Phosphoprotein Res.19902415191698404
   PubMedGoogle Scholar
• LukasRJ.ChangeuxJP.Le NovereN.et al.Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.Pharmacol Rev.19995139740110353988
   PubMed Web of Science ®Google Scholar
• Devillers-ThieryA.GalziJL.EiseleJL.BertrandS.BertrandD.ChangeuxJP.Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.J Membr Biol.1993136971127508983
   PubMed Web of Science ®Google Scholar
• MiyazawaA.FujiyoshiY.StowellM.UnwinN.Nicotinic acetylcholine receptor at 4.6 Å resolution: transverse tunnels in the channel wall.J Mol Biol.199928876578610329178
   PubMed Web of Science ®Google Scholar
• BertrandD.GalziJL.Devillers-ThieryA.BertrandS.ChangeuxJP.Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal α7 nicotinic receptor.Proc Natl Acad Sci U S A.199390697169757688468
   PubMed Web of Science ®Google Scholar
• SeguelaP.WadicheJ.Dineley-MillerK.DaniJA.PatrickJW.Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium.J Neurosci.1993135966047678857
   PubMed Web of Science ®Google Scholar
• HenningfieldJE.StapletonJM.BenowitzNL.GraysonRF.LondonED.Higher levels of nicotine in arterial than in venous blood after cigarette smoking.Drug Alcohol Depend.19933323298370337
   PubMed Web of Science ®Google Scholar
• Fabian-FineR.SkehelP.ErringtonML.et al.Ultrastructural distribution of the α7 nicotinic acetylcholine receptor subunit in rat hippocampus.J Neurosci.2001217993800311588172
   PubMed Web of Science ®Google Scholar
• SpurdenDP.CourtJA.LloydS.et al.Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I]α-bungarotoxin binding.J Chem Neuroanat.1997131051139285355
   PubMed Web of Science ®Google Scholar
• GallezotJD.BottlaenderM.GregoireMC.et al.In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fIuoro-A-85380 and PET.J Nucl Med.20054624024715695782
   PubMed Web of Science ®Google Scholar
• GundischD.KorenAO.HortiAG.et al.In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for α4β2* nicotinic acetylcholine receptors.Synapse.200555899715529332
   PubMed Web of Science ®Google Scholar
• KimesAS.HortiAG.LondonED.et al.2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans.Faseb J.2003171331133312759330
   PubMed Web of Science ®Google Scholar
• ClarkePB.PertA.Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.Brain Res.19853483553584075093
   PubMed Web of Science ®Google Scholar
• TribolletE.BertrandD.MargueratA.RaggenbassM.Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain.Neuroscience.200412440542014980390
   PubMed Web of Science ®Google Scholar
• WonnacottS.DrasdoA.SandersonE.RowellP.Presynaptic nicotinic receptors and the modulation of transmitter release.Ciba Found Symp.1990152871011976493
   PubMedGoogle Scholar
• BertrandD.ChangeuxJP.Nicotinic receptor: an allosteric protein specialized for intercellular communication.Seminar Neurosci.199577590
   Web of Science ®Google Scholar
• DaniJA.Overview of nicotinic receptors and their roles in the central nervous system.Biol Psychiatry.20014916617411230867
   PubMed Web of Science ®Google Scholar
• PicciottoMR.ZoliM.ChangeuxJP.Use of knock-out mice to determine the molecular basis for the actions of nicotine.Nicotine Tob Res.19991(suppl 2)S121S125 Discussion S139-S14011768168
   PubMedGoogle Scholar
• GiraudatJ.DennisM.HeidmannT.HaumontPY.LedererF.ChangeuxJP.Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains.Biochemistry.198726241024183607023
   PubMed Web of Science ®Google Scholar
• RanaB.McMornSO.ReeveHL.WyattCN.VaughanPF.PeersC.Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine.Eur J Pharmacol.19932502472517509283
   PubMed Web of Science ®Google Scholar
• Lopez-ValdesH.Garcia-ColungaJ.MilediR.Effects of clomipramine on neuronal nicotinic acetylcholine receptors.Eur J Pharmacol.2002444131912191577
   PubMed Web of Science ®Google Scholar
• AlkondonM.AlbuquerqueEX.Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional upregulation by nicotine and to block by bupropion.J Pharmacol Exp Ther.200531374075015647329
   PubMed Web of Science ®Google Scholar
• FryerJD.LukasRJ.Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.J Pharmacol Exp Ther.199928888929862757
   PubMed Web of Science ®Google Scholar
• BuissonB.BertrandD.Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor.Mol Pharmacol.1998535555639495824
   PubMed Web of Science ®Google Scholar
• HenningsEC.KissJP.De OliveiraK.TothPT.ViziES.Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices.J Neurochem.1999731043105010461893
   PubMed Web of Science ®Google Scholar
• PicardF.BertrandS.SteinleinOK.BertrandD.Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine.Epilepsia.1999401198120910487182
   PubMed Web of Science ®Google Scholar
• HenningsEC.KissJP.ViziES.Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices.Brain Res.19977592922949221950
   PubMed Web of Science ®Google Scholar
• ShytleRD.SilverAA.LukasRJ.NewmanMB.SheehanDV.SanbergPR.Nicotinic acetylcholine receptors as targets for antidepressants.Mol Psychiatry.2002752553512140772
   PubMed Web of Science ®Google Scholar
• ShytleRD.SilverAA.SheehanKH.SheehanDV.SanbergPR.Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine.Depress Anxiety.200216899212415531
   PubMed Web of Science ®Google Scholar
• LevinED.Nicotinic receptor subtypes and cognitive function.J Neurobiol.20025363364012436426
   PubMedGoogle Scholar
• ZaninettiM.RaggenbassM.Oxytocin receptor agonists enhance inhibitory synaptic transmission in the rat hippocampus by activating interneurons in stratum pyramidale.Eur J Neurosci.2000123975398411069593
   PubMed Web of Science ®Google Scholar
• ParadisoK.ZhangJ.SteinbachJH.The C terminus of the human nicotinic α4β2 receptor forms a binding site required for potentiation by an estrogenic steroid.J Neurosci.2001216561656811517245
   PubMed Web of Science ®Google Scholar
• ValeraS.BallivetM.BertrandD.Progesterone modulates a neuronal nicotinic acetylcholine receptor.Proc Natl Acad Sci U S A.199289994999531409725
   PubMed Web of Science ®Google Scholar
• CurtisL.BuissonB.BertrandS.BertrandD.Potentiation of human α4β2 neuronal nicotinic acetylcholine receptor by estradiol.Mol Pharmacol.20026112713511752213
   PubMed Web of Science ®Google Scholar
• HoggRC.RaggenbassM.BertrandD.Nicotinic acetylcholine receptors: from structure to brain function.Rev Physiol Biochem Pharmacol.200314714612783266
   PubMed Web of Science ®Google Scholar
• ZaninettiM.TribolletE.BertrandD.RaggenbassM.Nicotinic cholinergic activation of magnocellular neurons of the hypothalamic paraventricular nucleus.Neuroscience.200211028729911958870
   PubMed Web of Science ®Google Scholar
• SembaJ.WakutaM.MaedaJ.SuharaT.Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation.Psychoneuroendocrinology.20042921522614604602
   PubMed Web of Science ®Google Scholar
• BertrandD.ValeraS.BertrandS.BallivetM.RunggerD.Steroids inhibit nicotinic acetylcholine receptors.Neuroreport.199122772801717043
   PubMed Web of Science ®Google Scholar
• LambertJJ.BelelliD.PedenDR.VardyAW.PetersJA.Neurosteroid modulation of GABAA receptors.Prog Neurobiol.200371678014611869
   PubMed Web of Science ®Google Scholar
• DubrovskyBO.Steroids, neuroactive steroids and neurosteroids in psychopathology.Prog Neuropsychopharmacol Biol Psychiatry.20052916919215694225
   PubMed Web of Science ®Google Scholar
• PearsonH.Hormone therapy: a dangerous elixir?Nature.200443150050115457228
   PubMed Web of Science ®Google Scholar
• PerryDC.Davila-GarciaMl.StockmeierCA.KellarKJ.Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies.J Pharmacol Exp Ther.19992891545155210336551
   PubMed Web of Science ®Google Scholar
• TeaktongT.GrahamAJ.JohnsonM.CourtJA.PerryEK.Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study.Neuropathol Appl Neurobiol.20043024325415175078
   PubMed Web of Science ®Google Scholar
• KassiouM.EberlS.MeikleSR.et al.In vivo imaging of nicotinic receptor upregulation following chronic (-)-nicotine treatment in baboon using SPECT.Nucl Med Biol.20012816517511295427
   PubMed Web of Science ®Google Scholar
• BuissonB.BertrandD.Chronic exposure to nicotine upregulates the human (α)4(β)2 nicotinic acetylcholine receptor function.J Neurosci.2001211819182911245666
   PubMed Web of Science ®Google Scholar
• Abreu-VillacaY.SeidlerFJ.TateCA.CousinsMM.SlotkinTA.Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal.Neuropsychopharmacology.20042987989014970833
   PubMed Web of Science ®Google Scholar
• NarayananU.BirruS.VaglenovaJ.BreeseCR.Nicotinic receptor expression following nicotine exposure via maternal milk.Neuroreport.20021396196312004199
   PubMed Web of Science ®Google Scholar
• AwtryTL.WerlingLL.Acute and chronic effects of nicotine on serotonin uptake in prefrontal cortex and hippocampus of rats.Synapse.20035020621114515338
   PubMed Web of Science ®Google Scholar
• BalfourDJ.RidleyDL.The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?Pharmacol Biochem Behav.200066798510837846
   PubMed Web of Science ®Google Scholar
• KillenJD.FortmannSP.SchatzbergAF.HaywardC.VaradyA.Onset of major depression during treatment for nicotine dependence.Addict Behav.20032846147012628619
   PubMed Web of Science ®Google Scholar
• HaroR.Drucker-ColinR.A 2-year study on the effects of nicotine and its withdrawal on mood and sleep.Pharmacopsychiatry.20043722122715470801
   PubMed Web of Science ®Google Scholar
• Saint-MieuxB.EggermannE.BisettiA.et al.Nicotinic enhancement of the noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area.J Neurosci.200424636714715938
   PubMed Web of Science ®Google Scholar
• SteinleinOK.Genetic mechanisms that underlie epilepsy.Nat Rev Neurosci.2004540040815100722
   PubMed Web of Science ®Google Scholar
• LenigerT.KananuraC.HufnagelA.BertrandS.BertrandD.SteinleinOK.A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.Epilepsia.20034498198512823585
   PubMed Web of Science ®Google Scholar
• PhillipsHA.FavreI.KirkpatrickM.et al.CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy.Am J Hum Genet.20016822523111104662
   PubMed Web of Science ®Google Scholar